Long‐term efficacy of SGLT2 inhibitors for elderly patients with acute decompensated heart failure: The OASIS‐HF study

Aims Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) have been widely demonstrated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization, regardless of left ventricular ejection fraction (LVEF). However, data on the extent to which rehospitalization is suppressed follo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	ESC Heart Failure Ročník 12; číslo 1; s. 447 - 455
Hlavní autoři:	Amioka, Michitaka, Kinoshita, Hiroki, Fuji, Yuto, Nitta, Kazuhiro, Yamane, Kenichi, Shokawa, Tomoki, Nakano, Yukiko
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England John Wiley & Sons, Inc 01.02.2025 John Wiley and Sons Inc Wiley
Témata:	Acute Disease Aged Aged, 80 and over Beta blockers Blood pressure Cardiovascular death Demographics Diabetes Diuretics Ejection fraction Female Follow-Up Studies Glomerular Filtration Rate Heart failure Heart Failure - drug therapy Heart Failure - mortality Heart Failure - physiopathology Hospitalization Humans Male Original Patient Readmission - trends Patients Prospective Studies Quality of life Rehospitalization Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Sodium‐glucose cotransporter 2 inhibitors Stroke Volume - physiology Survival Rate - trends Time Factors Treatment Outcome Variables Ventricular Function, Left - physiology Heart failure Cardiovascular death Rehospitalization Sodium‐glucose cotransporter 2 inhibitors Ejection fraction
ISSN:	2055-5822, 2055-5822
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!